CNS & Neurological Disorders - Drug Targets
Title: Editorial [Hot Topic:Depression (Part 1) (Guest Editors: John H. Kehne and Ronald S. Duman)]
Volume: 6 Issue: 2
Author(s): Ronald S. Duman and John H. Kehne
Affiliation:
Export Options
About this article
Cite this article as:
Duman S. Ronald and Kehne H. John, Editorial [Hot Topic:Depression (Part 1) (Guest Editors: John H. Kehne and Ronald S. Duman)], CNS & Neurological Disorders - Drug Targets 2007; 6 (2) . https://dx.doi.org/10.2174/187152707780363249
DOI https://dx.doi.org/10.2174/187152707780363249 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities
Current Drug Targets GABAB Receptors-Associated Proteins: Potential Drug Targets in Neurological Disorders?
Current Drug Targets Biological Therapies of Autoimmune Diseases
Current Drug Targets - Inflammation & Allergy Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design A Review of Selected Adult Congenital Heart Diseases Encountered in Daily Practice
Current Cardiology Reviews Resistance to Crizotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) with ALK Rearrangement: Mechanisms, Treatment Strategies and New Targeted Therapies
Current Clinical Pharmacology Aberrant DNA Methylation Pattern may Enhance Susceptibility to Migraine: A Novel Perspective
CNS & Neurological Disorders - Drug Targets Unusual Clinical Manifestations of the Antiphospholipid Syndrome
Current Rheumatology Reviews Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine
Current Medicinal Chemistry Liver Injury Associated with Antidepressants
Current Drug Safety The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Docking Studies for Multi-Target Drugs
Current Drug Targets MicroRNAs: An Apparent Switch for High-Altitude Pulmonary Edema
MicroRNA Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
Current Medicinal Chemistry Real-world Utilisation of the Rivastigmine Transdermal Patches Accompanying the Use of Risk Minimisation Tools in Patients with Dementia
Current Alzheimer Research Hypersensitivity Reactions to Ophthalmic Products
Current Pharmaceutical Design Interactions between Ketamine and Magnesium for the Treatment of Pain: Current State of the Art
CNS & Neurological Disorders - Drug Targets Adverse Effects of Tacrolimus in Renal Transplant Patients from Living Donors
Current Drug Safety In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats
Drug Metabolism Letters New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Current Drug Targets